Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Multiple Sclerosis Drugs Market Research Reports

Titlepublishedprice

United States Fingolimod Market Report 2017

By QYResearch Group
"...... The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Fingolimod in these regions, from 2012 to 2022 (foreca......"
18-Sep-2017$3800

Global Fingolimod Sales Market Report 2017

By QYResearch Group
"...... (Million USD), market share and growth rate of Fingolimod for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast Asia - India Global Fing......"
13-Sep-2017$4000

Global Multiple Sclerosis Partnering 2010 to 2017

By Current Partnering
"...... - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals ......"
01-Sep-2017$1495

Global Fingolimod Market Research Report 2017

By QYResearch Group
"...... , revenue (million USD), market share and growth rate of Fingolimod in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Global Fin......"
31-Aug-2017$2900

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017

By Delve Insight
"...... vities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy type, route of administration and molecule type is ......"
28-Jul-2017$1250

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017

By Delve Insight
"...... inical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and molecule type is also covered in the report. It al......"
28-Jul-2017$1250

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2017

By Delve Insight
"...... activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Secondary Progressive Multiple Sclerosis (SPMS) by development stage, therapy type, route of administration and molecule ty......"
28-Jul-2017$1250

Primary Progressive Multiple Sclerosis (PPMS) - Epidemiology Insights to 2025

By Delve Insight
"...... storical and forecasted data of Primary Progressive Multiple Sclerosis (PPMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Primary Progressive Multiple Scl......"
28-Jul-2017$2950

Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... in and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Primary Progressive Multiple Sclerosis (PPM......"
28-Jul-2017$5750

Relapsing Multiple Sclerosis (RMS) - Epidemiology Insights to 2025

By Delve Insight
"...... d data of Relapsing Multiple Sclerosis (RMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Relapsing Multiple Sclerosis (RMS). The report contains the targe......"
28-Jul-2017$2950

Avail upto 25% Discount on below Publisher Reports.